Back to top

The drug is an anti-inflammatory that has been prescribed for gout, but there's evidence the medicine could help fight against COVID-19.

In Early Trial, an Ancient Drug Shows Promise Against Severe COVID-19

WEDNESDAY, June 24, 2020 (HealthDay News) -- There's new evidence that a 2,000-year-old medicine might offer hope against a modern scourge: COVID-19.

The medication, called colchicine, is an anti-inflammatory taken as a pill. It's long been prescribed for gout, a form of arthritis, and its history goes back centuries. The drug was first sourced from the autumn crocus flower.

Doctors also sometimes use colchicine to treat pericarditis, where the sac around the heart becomes inflamed.

Read the full HealthDay story.

From arguments and friction to sex and affection, see how the recent stay-at-home lockdowns have affected couples across the country.

Love During Lockdown: Survey Shows How Couples Have Coped

THURSDAY, June 11, 2020 (HealthDay News) -- As U.S. states issued stay-at-home orders in March and April, one of many questions was how couples would fare under lockdown together. Now a new survey offers an initial snapshot: some more arguments, regular declarations of love, and a good dose of same-old, same-old.

The survey included close to 2,300 U.S. adults who were living with their partner when the pandemic hit -- forcing most to hunker down at home.

For some couples, the extra together time caused friction: One-quarter of respondents admitted to more arguments with their partner.

Read the full HealthDay story.

A new study warns that the COVID-19 pandemic may be keeping people from seeking help for suicidal thoughts.

Fewer Suicide-Related ER Visits in COVID Era, and That Has Experts Worried

MONDAY, June 8, 2020 (HealthDay News) -- The COVID-19 pandemic has had far-reaching effects, and a new study points to yet another: It may be keeping people from seeking emergency care for suicidal thoughts.

The study, at one large Ohio health system, found that ER visits for suicidal ideation dropped by over 60% in the month after the state instituted its stay-at-home order.

And that's concerning, researchers said, because, if anything, this is a time when mental health needs are expected to be more acute than ever.

Read the full HealthDay story.

One symptom of COVID-19 is the loss of smell or taste, and doctors worry it might be permanent in a small number of people who experience it.

Loss of Smell, Taste Might Be Long-Term for Some COVID-19 Survivors

THURSDAY, June 4, 2020 (HealthDay News) -- Since the start of the COVID-19 pandemic, it's become clear that many people with the infection lose their sense of smell and taste. And doctors are concerned that some will never get back to normal.

At this point, it's hard to know how common the symptom is. First, there were anecdotal reports of COVID-19 patients who had lost their ability to smell or taste, said Dr. Nicholas Rowan, an assistant professor of otolaryngology-head and neck surgery at Johns Hopkins University in Baltimore.

And then, he said, studies started to confirm "there's a lot of truth to it."

Read the full HealthDay story.

A measles outbreak in New York City last year that sickened 649 people could provide clues on how to respond to the current COVID-19 pandemic.

Last Year's NYC Measles Outbreak Has Lessons for COVID Crisis

TUESDAY, June 2, 2020 (HealthDay News) -- In a finding that could help guide the response to the coronavirus pandemic, new research shows that a measles outbreak that struck New York City last year could have been much worse if the city had not launched a vaccine campaign.

The measles outbreak -- the largest in the United States in nearly three decades -- ultimately sickened 649 people. Most were children in a Brooklyn Orthodox Jewish community.

It all began fall of 2018 when an unvaccinated child returned home from a trip to Israel infected with the measles virus. Low vaccination rates in the local Orthodox community allowed the infection to spread.

Read the full HealthDay story.

A new research review suggests that yoga can help ease depression symptoms.

Lockdown Got You Feeling Low? Yoga May Help

THURSDAY, May 21, 2020 (HealthDay News) -- Many people under stay-at-home orders have turned to online yoga as a way to manage the stress. And a new research review suggests they're onto something.

The review, of 19 clinical trials, focused on the benefits of yoga for people with clinical mental health conditions ranging from anxiety disorders to alcohol dependence to schizophrenia. Overall, it found yoga classes helped ease those patients' depression symptoms.

And while the trials focused on in-person classes for people with formal diagnoses, there are broader implications, the researchers said.

Read the full HealthDay story.

Though research on reinfection of COVID-19 specifically isn't available because it's still so new, one study took a look at if people who've had other coronaviruses and recovered are immune to them afterward.

Can Survivors Get Reinfected With Coronavirus?

MONDAY, May 4, 2020 (HealthDay News) -- People all over the globe who've recovered from the new coronavirus want to know the same thing: Am I immune, at least for a while? A new study of common coronaviruses is not exactly reassuring.

Researchers found it was "not uncommon" for people with run-of-the-mill coronaviruses (not the one that causes COVID-19) to have a repeat infection within a year. Of 86 New York City residents infected with those coronaviruses, 12 tested positive for the same bug again.

A big caveat is, the study looked only at the four coronaviruses that are endemic in humans -- the kind that cause nothing worse than cold symptoms.

"They're kind of wimpy," said researcher Jeffrey Shaman, a professor of environmental health sciences at Columbia University Mailman School of Public Health. "People rarely have to go to the doctor for these infections."

So it's hard to know, Shaman said, whether our experiences with endemic coronaviruses will translate to SARS-CoV-2 -- the coronavirus that causes COVID-19.

"It's not the same as these endemic viruses," Shaman said. "But obviously, we can't look at repeat infections with [SARS-CoV-2], because it's new."

In lieu of that, he said, analyzing the patterns of regular coronaviruses -- how often reinfections occur, and in what time frame -- may at least give a sense of what could happen with the new virus.

Read the full HealthDay story.

Experts share how to keep the peace when you and your spouse are both stuck at home during sheltering-in-place orders.

Love in the Time of Coronavirus: Couples Feel the Strain of Lockdown

TUESDAY, April 28, 2020 (HealthDay News) -- With most Americans weeks into sheltering-in-place, couples are in a situation probably none ever planned for: Being in each other's faces all day, every day -- with no clear end in sight.

Experts say the new closeness is likely playing out in many ways: Some couples will find they enjoy the extra time with each other; others will be counting the days until they can be with a human other than their beloved.

On the far end of the spectrum, the worst consequences of home lockdown are already manifesting: The United Nations has reported a sharp rise in domestic violence globally.

Many couples, though, will face issues that do not escalate to that severity -- but are not minor, either.

The pandemic has ushered in a wave of new stresses, from the health threat itself to job and income losses. At the same time, many of the usual coping strategies have evaporated, too, said Katherine Hertlein, a professor of couple and family therapy at the University of Nevada, Las Vegas.

If you usually deal with a spat by going to the gym to cool your head, that's fine, Hertlein said -- as long as you talk about the issue later. But that option is no longer on the table. Neither is going to a movie, or yoga class, or meeting friends.

"People weren't given the chance to develop new coping strategies before this all went down," Hertlein said. So couples are left to figure it out -- or not -- as they go along.

Read the full HealthDay story.

Latest